[go: up one dir, main page]

GB201603653D0 - Combination Therapy - Google Patents

Combination Therapy

Info

Publication number
GB201603653D0
GB201603653D0 GBGB1603653.5A GB201603653A GB201603653D0 GB 201603653 D0 GB201603653 D0 GB 201603653D0 GB 201603653 A GB201603653 A GB 201603653A GB 201603653 D0 GB201603653 D0 GB 201603653D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1603653.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB1603653.5A priority Critical patent/GB201603653D0/en
Publication of GB201603653D0 publication Critical patent/GB201603653D0/en
Priority to PCT/GB2017/050553 priority patent/WO2017149306A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1603653.5A 2016-03-02 2016-03-02 Combination Therapy Ceased GB201603653D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1603653.5A GB201603653D0 (en) 2016-03-02 2016-03-02 Combination Therapy
PCT/GB2017/050553 WO2017149306A1 (en) 2016-03-02 2017-03-02 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1603653.5A GB201603653D0 (en) 2016-03-02 2016-03-02 Combination Therapy

Publications (1)

Publication Number Publication Date
GB201603653D0 true GB201603653D0 (en) 2016-04-13

Family

ID=55807199

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1603653.5A Ceased GB201603653D0 (en) 2016-03-02 2016-03-02 Combination Therapy

Country Status (2)

Country Link
GB (1) GB201603653D0 (en)
WO (1) WO2017149306A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111939245B (en) * 2019-05-16 2024-03-01 龚笑海 Pharmaceutical composition for heart treatment and protection
US20230285506A1 (en) * 2019-12-03 2023-09-14 Acceleron Pharma Inc. Compositions and methods for treating pulmonary hypertension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067006A1 (en) * 2003-01-27 2004-08-12 Pharmacia Corporation Combination of a pde iv inhibitor and a tnf-alpha antagonist
AU2009272680A1 (en) * 2008-07-18 2010-01-21 Novozymes Adenium Biotech A/S Treatment of inflammatory diseases with mammal beta defensins
GB201412290D0 (en) * 2014-07-10 2014-08-27 Cambridge Entpr Ltd Novel use

Also Published As

Publication number Publication date
WO2017149306A1 (en) 2017-09-08

Similar Documents

Publication Publication Date Title
IL263521A (en) Combination therapy
IL265406B (en) Combination therapy
GB201516442D0 (en) Combination therapy
IL257976A (en) Combination therapy
ZA201804155B (en) Combination therapy
GB201609597D0 (en) Therapy
GB201604318D0 (en) Combination therapy
GB201604316D0 (en) Combination therapy
IL265340A (en) Combination therapy
GB201609735D0 (en) Combination therapy
GB201603653D0 (en) Combination Therapy
GB201618477D0 (en) Therapy
GB201613179D0 (en) Combination therapy
GB201609722D0 (en) Combination therapy
GB201609766D0 (en) Combination therapy
GB201609770D0 (en) Combination therapy
GB201609719D0 (en) Combination therapy
GB201604319D0 (en) Combination therapy
GB201604317D0 (en) Combination therapy
GB201615923D0 (en) Macrophage-based therapy
GB201706222D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy
GB201706224D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)